Blood markers may predict crush syndrome death risk
NCT ID NCT07433127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviewed medical records of 325 adults with crush syndrome in the ICU to see if certain blood-based inflammation scores could predict who would die within 28 days. Researchers compared these scores to standard severity tools. The goal was to learn if a simple blood test could help doctors identify high-risk patients earlier.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ataturk University Research Hospital
Erzurum, 20100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- A gentle touch from family may calm the ICU storm
- Fixing sleep, fortifying hearts: a new trial tests the link
- Can remote exercise rebuild strength in kids after ICU?